• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两亲性大分子的碳水化合物组成影响其理化性质和与动脉粥样硬化性清道夫受体 A 的结合。

Carbohydrate composition of amphiphilic macromolecules influences physicochemical properties and binding to atherogenic scavenger receptor A.

机构信息

Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA.

出版信息

Acta Biomater. 2012 Nov;8(11):3956-62. doi: 10.1016/j.actbio.2012.07.022. Epub 2012 Jul 24.

DOI:10.1016/j.actbio.2012.07.022
PMID:22835678
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3462273/
Abstract

Amphiphilic macromolecules (AMs) based on carbohydrate domains functionalized with poly(ethylene glycol) can inhibit the uptake of oxidized low density lipoprotein (oxLDL) mediated by scavenger receptor A (SR-A) and counteract foam cell formation, the characteristic "atherosclerotic" phenotype. A series of AMs was prepared by altering the carbohydrate chemistry to evaluate the influence of backbone architecture on the physicochemical and biological properties. Upon evaluating the degree of polymer-based inhibition of oxLDL uptake in human embryonic kidney cells expressing SR-A, two AMs (2a and 2c) were found to have the most efficacy. Molecular modeling and docking studies show that these same AMs have the most favorable binding energies and most close interactions with the molecular model of the SR-A collagen-like domain. Thus, minor changes in the AMs' architecture can significantly affect the physicochemical properties and inhibition of oxLDL uptake. These insights can be critical for designing optimal AM-based therapeutics for the management of cardiovascular disease.

摘要

基于糖基化的两亲性大分子(AMs)通过聚乙二醇(PEG)功能化,可以抑制清道夫受体 A(SR-A)介导的氧化型低密度脂蛋白(oxLDL)摄取,从而阻止泡沫细胞的形成,这是动脉粥样硬化的特征性表型。通过改变糖化学结构,我们制备了一系列 AMs,以评估主链结构对其理化和生物学性质的影响。在评估表达 SR-A 的人胚肾细胞中聚合物对 oxLDL 摄取的抑制程度时,发现两种 AM(2a 和 2c)具有最高的功效。分子建模和对接研究表明,这两种 AM 与 SR-A 胶原样结构域的分子模型具有最有利的结合能和最紧密的相互作用。因此,AM 结构的微小变化可显著影响其理化性质和 oxLDL 摄取的抑制效果。这些见解对于设计基于 AM 的治疗心血管疾病的最佳治疗方法至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6763/3462273/1f0a52b3c517/nihms401528f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6763/3462273/9be5f8c02b24/nihms401528f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6763/3462273/4d7d6e348d1f/nihms401528f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6763/3462273/1f0a52b3c517/nihms401528f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6763/3462273/9be5f8c02b24/nihms401528f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6763/3462273/4d7d6e348d1f/nihms401528f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6763/3462273/1f0a52b3c517/nihms401528f3.jpg

相似文献

1
Carbohydrate composition of amphiphilic macromolecules influences physicochemical properties and binding to atherogenic scavenger receptor A.两亲性大分子的碳水化合物组成影响其理化性质和与动脉粥样硬化性清道夫受体 A 的结合。
Acta Biomater. 2012 Nov;8(11):3956-62. doi: 10.1016/j.actbio.2012.07.022. Epub 2012 Jul 24.
2
Nanoscale amphiphilic macromolecules with variable lipophilicity and stereochemistry modulate inhibition of oxidized low-density lipoprotein uptake.具有可变疏水性和立体化学的纳米级两亲性大分子调节氧化型低密度脂蛋白摄取的抑制作用。
Biomacromolecules. 2013 Aug 12;14(8):2463-9. doi: 10.1021/bm400537w. Epub 2013 Jul 8.
3
Tartaric acid-based amphiphilic macromolecules with ether linkages exhibit enhanced repression of oxidized low density lipoprotein uptake.具有醚键的基于酒石酸的两亲性大分子对氧化型低密度脂蛋白摄取的抑制作用增强。
Biomaterials. 2015 Jun;53:32-9. doi: 10.1016/j.biomaterials.2015.02.038. Epub 2015 Mar 7.
4
Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation.两亲性大分子作为胆固醇流出触发因子和巨噬细胞动脉粥样炎症抑制剂的双重用途。
Biomaterials. 2011 Nov;32(32):8319-27. doi: 10.1016/j.biomaterials.2011.07.039. Epub 2011 Aug 3.
5
Coarse grained molecular dynamics of engineered macromolecules for the inhibition of oxidized low-density lipoprotein uptake by macrophage scavenger receptors.工程化大分子的粗粒分子动力学研究用于抑制巨噬细胞清道夫受体摄取氧化型低密度脂蛋白。
Biomacromolecules. 2013 Aug 12;14(8):2499-509. doi: 10.1021/bm301764x. Epub 2013 Jul 3.
6
In silico design of anti-atherogenic biomaterials.抗动脉粥样硬化生物材料的计算机辅助设计。
Biomaterials. 2013 Oct;34(32):7950-9. doi: 10.1016/j.biomaterials.2013.07.011. Epub 2013 Jul 25.
7
Impact of hydrophobic chain composition on amphiphilic macromolecule antiatherogenic bioactivity.疏水链组成对两亲性大分子抗动脉粥样硬化生物活性的影响。
Biomacromolecules. 2014 Sep 8;15(9):3328-37. doi: 10.1021/bm500809f. Epub 2014 Aug 6.
8
Sugar-based amphiphilic polymers for biomedical applications: from nanocarriers to therapeutics.用于生物医学应用的糖基两亲聚合物:从纳米载体到治疗剂。
Acc Chem Res. 2014 Oct 21;47(10):2867-77. doi: 10.1021/ar4003009. Epub 2014 Aug 20.
9
Structure-activity relations of nanolipoblockers with the atherogenic domain of human macrophage scavenger receptor A.纳米脂质阻滞剂与人类巨噬细胞清道夫受体A致动脉粥样化结构域的构效关系
Biomacromolecules. 2009 Jun 8;10(6):1381-91. doi: 10.1021/bm8014522.
10
Amphiphilic macromolecule nanoassemblies suppress smooth muscle cell proliferation and platelet adhesion.两亲性大分子纳米组装体抑制平滑肌细胞增殖和血小板黏附。
Biomaterials. 2016 Apr;84:219-229. doi: 10.1016/j.biomaterials.2015.12.033. Epub 2016 Jan 4.

引用本文的文献

1
-Xylene Oxidation to Terephthalic Acid: New Trends.二甲苯氧化制对苯二甲酸:新趋势。
Molecules. 2023 Feb 17;28(4):1922. doi: 10.3390/molecules28041922.
2
The Role of Macrophages in the Pathogenesis of Atherosclerosis.巨噬细胞在动脉粥样硬化发病机制中的作用。
Cells. 2023 Feb 5;12(4):522. doi: 10.3390/cells12040522.
3
Identification of Monocyte-Associated Genes Related to the Instability of Atherosclerosis Plaque.鉴定与动脉粥样硬化斑块不稳定性相关的单核细胞相关基因。

本文引用的文献

1
Kinetically assembled nanoparticles of bioactive macromolecules exhibit enhanced stability and cell-targeted biological efficacy.生物活性大分子的动力学组装纳米颗粒表现出增强的稳定性和细胞靶向的生物功效。
Adv Mater. 2012 Feb 7;24(6):733-9. doi: 10.1002/adma.201103348. Epub 2012 Jan 2.
2
Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation.两亲性大分子作为胆固醇流出触发因子和巨噬细胞动脉粥样炎症抑制剂的双重用途。
Biomaterials. 2011 Nov;32(32):8319-27. doi: 10.1016/j.biomaterials.2011.07.039. Epub 2011 Aug 3.
3
Controllable inhibition of cellular uptake of oxidized low-density lipoprotein: structure-function relationships for nanoscale amphiphilic polymers.
Oxid Med Cell Longev. 2022 Sep 21;2022:3972272. doi: 10.1155/2022/3972272. eCollection 2022.
4
Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential.低密度脂蛋白纳米药物:靶向机制、生物学和治疗诊断潜力。
Drug Deliv. 2021 Dec;28(1):408-421. doi: 10.1080/10717544.2021.1886199.
5
Scavenger Receptors as Biomarkers and Therapeutic Targets in Cardiovascular Disease.清道夫受体作为心血管疾病的生物标志物和治疗靶点。
Cells. 2020 Nov 10;9(11):2453. doi: 10.3390/cells9112453.
6
Nanotherapeutics Containing Lithocholic Acid-Based Amphiphilic Scorpion-Like Macromolecules Reduce In Vitro Inflammation in Macrophages: Implications for Atherosclerosis.含有基于石胆酸的两亲性蝎形大分子的纳米治疗剂可减轻巨噬细胞的体外炎症:对动脉粥样硬化的影响。
Nanomaterials (Basel). 2018 Feb 2;8(2):84. doi: 10.3390/nano8020084.
7
Micellar and structural stability of nanoscale amphiphilic polymers: Implications for anti-atherosclerotic bioactivity.纳米级两亲聚合物的胶束与结构稳定性:对抗动脉粥样硬化生物活性的影响。
Biomaterials. 2016 Apr;84:230-240. doi: 10.1016/j.biomaterials.2015.12.028. Epub 2016 Jan 6.
8
Amphiphilic macromolecule nanoassemblies suppress smooth muscle cell proliferation and platelet adhesion.两亲性大分子纳米组装体抑制平滑肌细胞增殖和血小板黏附。
Biomaterials. 2016 Apr;84:219-229. doi: 10.1016/j.biomaterials.2015.12.033. Epub 2016 Jan 4.
9
Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques.用于抑制动脉粥样硬化形成和调节动脉粥样硬化斑块炎症的纳米疗法。
Cardiovasc Res. 2016 Feb 1;109(2):283-93. doi: 10.1093/cvr/cvv237. Epub 2015 Oct 14.
10
Tartaric acid-based amphiphilic macromolecules with ether linkages exhibit enhanced repression of oxidized low density lipoprotein uptake.具有醚键的基于酒石酸的两亲性大分子对氧化型低密度脂蛋白摄取的抑制作用增强。
Biomaterials. 2015 Jun;53:32-9. doi: 10.1016/j.biomaterials.2015.02.038. Epub 2015 Mar 7.
可控制的氧化型低密度脂蛋白细胞摄取抑制:纳米两亲聚合物的结构-功能关系。
Acta Biomater. 2010 Aug;6(8):3081-91. doi: 10.1016/j.actbio.2010.02.019. Epub 2010 Feb 17.
4
Structure-activity relations of nanolipoblockers with the atherogenic domain of human macrophage scavenger receptor A.纳米脂质阻滞剂与人类巨噬细胞清道夫受体A致动脉粥样化结构域的构效关系
Biomacromolecules. 2009 Jun 8;10(6):1381-91. doi: 10.1021/bm8014522.
5
Stereospecific interaction between immune cells and chiral surfaces.免疫细胞与手性表面之间的立体特异性相互作用。
J Am Chem Soc. 2007 Feb 14;129(6):1496-7. doi: 10.1021/ja0686155.
6
Class A scavenger receptor-mediated cell adhesion requires the sequential activation of Lyn and PI3-kinase.A类清道夫受体介导的细胞黏附需要Lyn和PI3激酶的顺序激活。
Am J Physiol Cell Physiol. 2007 Apr;292(4):C1450-8. doi: 10.1152/ajpcell.00401.2006. Epub 2006 Dec 27.
7
Engineered polymeric nanoparticles for receptor-targeted blockage of oxidized low density lipoprotein uptake and atherogenesis in macrophages.工程化聚合物纳米颗粒用于受体靶向阻断巨噬细胞中氧化低密度脂蛋白的摄取及动脉粥样硬化的发生。
Biomacromolecules. 2006 Jun;7(6):1796-805. doi: 10.1021/bm0600872.
8
Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDL.纳米级阴离子大分子可抑制细胞对不同氧化程度的低密度脂蛋白的摄取。
Biomacromolecules. 2006 Feb;7(2):597-603. doi: 10.1021/bm0506905.
9
Control of scavenger receptor-mediated endocytosis by novel ligands of different length.不同长度新型配体对清道夫受体介导的内吞作用的调控
Mol Cell Biochem. 2005 Mar;271(1-2):123-32. doi: 10.1007/s11010-005-5756-3.
10
Hydroxyl stereochemistry and amine number within poly(glycoamidoamine)s affect intracellular DNA delivery.聚(糖酰胺胺)中的羟基立体化学和胺值影响细胞内DNA传递。
J Am Chem Soc. 2005 Mar 9;127(9):3004-15. doi: 10.1021/ja0436446.